← Product Code [HKI](/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKI) · K040325 # PANORET, MODEL PNM 60 (K040325) _Medibell Medical Vision Technologies , Ltd. · HKI · Mar 8, 2004 · Ophthalmic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKI/K040325 ## Device Facts - **Applicant:** Medibell Medical Vision Technologies , Ltd. - **Product Code:** [HKI](/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKI.md) - **Decision Date:** Mar 8, 2004 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 886.1120 - **Device Class:** Class 2 - **Review Panel:** Ophthalmic ## Intended Use The PNM 60 is a diagnostic device indicated to provide digital photographs of the interior of the eye as well as the anterior segment and external part of the eye. ## Device Story PNM 60 is a digital retinoscope modification of the Panoret 1000A. Device utilizes transcleral illumination; optics separate illumination path from imaging path to enable non-mydriatic wide-angle imaging. Primary modification involves reduction of viewing angle from 100 degrees (Panoret 1000A) to 60 degrees. Device captures digital photographs of eye interior, anterior segment, and external eye parts. Built-in light controls adjusted to compensate for changes in spectral radiant power distribution and photometric luminance. Used by clinicians for diagnostic imaging; output allows visual assessment of ocular structures to support clinical decision-making. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Transcleral illumination; separate illumination and imaging optical paths; non-mydriatic wide-angle imaging; 60-degree viewing angle. Complies with IEC-60601-1 safety standards. Includes adjustable built-in light controls for spectral radiant power and photometric luminance management. ## Regulatory Identification An ophthalmic camera is an AC-powered device intended to take photographs of the eye and the surrounding area. ## Special Controls *Classification.* Class II (special controls). The device, when it is a photorefractor or a general-use ophthalmic camera, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9. ## Predicate Devices - Panoret 1000A ([K001111](/device/K001111.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ MAR - 8 2004 # 510(k) Summary of Safety and Effectiveness (in accordinate to 21 CFR 307.87(h)) ## Device Name Proprietary Device Name : PNM 60. ## Establishment Name and Registration Number of Submitter Name: MEDIBELL, MEDICAL VISION TECHNOI.OGHES LTD Registration: 3003809739 Corresponding Official: Dan Laor MATAM Haifa, 31905 Israel ## Device Classification Classification Code: Regulation Number: Panel Identification: Classification Class: 86 HKI 886.1120 Ophthalmic Class II Product #### Reason for 510(k) Submission Modification of a legally marketed device. Special 510(K) ## Identification of Legally Marketed Equivalent Devices K001111 Panoret 1000A ## Device Description The PNM 60 is a modification of the legally marketed Panoret 1000 A K001111 Digital Retinoscope. It is based on transcleral illumination. Its optics distinguishes the illumination path from the imaging path, thus, enables non mydriatic wide angle imaging. The Panoret viewing angle has been changed from (Panoret 1000A) 100 degrees to PNM 60 degrees ## Intended Use of Device The PNM 60 is a diagnostic device indicated to provide digital photographs of the interior of the eye as well as the anterior segment and external part of the eye, #### Safety & effectiveness information Panoret PNM device is designed to comply with the requirements of the IEC-60601-1 safety standard. Brightness control: The relative spectral radiant power distribution and the photometric luminance have been changed. The device built-in light controls and the device operation have been adjusted to compensate for the modification. #### Substantial Equivalency It is Medibell opinion that the PNM 60 is substantially equivalent in terms of safety and effectiveness to the legally marketed Panoret 1000A K001 111. {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human figures, possibly representing a family or community, with their arms raised in a gesture of support or unity. Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 MAR - 8 2004 Medibell Medical Vision Technologies Ltd. c/o Dan Laor, General Manager MATAM Haifa, 31905 Israel Re: K040325 Trade/Device Name: PNM 60 Regulation Number: 21 CFR 886.1120 Regulation Name: O phthalmic camera Regulatory Class: Class II Product Code: HKI Dated: February 5, 2004 Received: February 17, 2004 Dear Mr. Laor: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {2}------------------------------------------------ Page 2 - Dan Laor, General Manager This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, A. Ralph Rosenthal A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ K040325 510(k) Number (if known): DEVICE NAME: INDICATION FOR USE: The PNM 60 is a diagnostic device indicated to provide digital photographs of the interior of the eye as well as the anterior segment and external part of the eye. (Please do not write below this line - continue on another page if needed) ( Concurrence of CDRH, Office of Device Evaluation (ODE) ) Denis L. McCarthy Division of Ophthalmic Ear, Nose and Throat Devises 6325 Prescription Use______________________________________________________________________________________________________________________________________________________________ (Per 21 CFR 801.109) Over-the-Counter Use_ OR --- **Source:** [https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKI/K040325](https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HKI/K040325) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com